Searched for
KOTAK STAKE
SBI Funds Management gets Sebi nod for IPOSBI Funds Management, India's largest mutual fund house, has secured SEBI's nod for its upcoming Initial Public Offering, expected to launc...- Reliance unveils India's biggest IPO plan as Jio Platforms files DRHPJio Platforms, Reliance Industries' digital arm, has filed for India's largest-ever public issue, aiming to raise a record $4 billion. This...
- Societe General, Prudential, others buy 3 per cent stake in Anthem Biosciences for Rs 1,275 crGlobal investors including Societe Generale and Prudential Hong Kong, alongside Indian mutual funds and insurance companies, have bought a ...
- JioBlackRock Flexi Cap Fund exits Adani Enterprises, Adani Ports and 3 other companies; adds Tata Motors and 14 more stocksJioBlackRock Flexi Cap Fund exited Adani Enterprises, Adani Ports and three other stocks in May while adding Tata Motors and 14 new stocks ...
- KKR eyes at least $1 billion stake in Medicover's India hospital arm, source saysGlobal investment firm KKR is in advanced discussions to acquire a significant stake in Medicover's Indian hospital operations. The deal is...
- NSE IPO: 7 PSU shareholders to offload 8 crore shares in mega public offerSeven government-owned entities, including State Bank of India and Bank of Baroda, will sell stakes in the National Stock Exchange through ...
- Vedanta Aluminium shares jump over 3% after Citi, Kotak initiate with Buy, see up to 29% upside. Here’s whyVedanta Aluminium Metal shares surged over 3% after Citi and Kotak Institutional Equities initiated coverage with 'Buy' ratings and target ...
- En route to D-Street: NSE files draft papers with SebiThe National Stock Exchange has filed its draft prospectus with Sebi, moving closer to its long-awaited Initial Public Offering. The IPO is...
- HDFC MF, ADIA among buyers as Sepia Investments offloads Rs 749 crore in Corona Remedies via block dealSepia Investments and Anchor Partners sold shares worth about Rs 777 crore in Corona Remedies through block deals. HDFC Mutual Fund emerged...
- Manipal Hospitals is said to plan $1 billion IPO in JulyManipal Health Enterprises is likely to launch its IPO as early as next month, targeting a valuation of around $10 billion. Backed by Temas...
- ET Alpha Wealth Summit | FIIs haven't abandoned India, they've just reshuffled: Samir AroraForeign investors are not leaving India. They are shifting investments from top companies to other stocks. This rotation involves billions ...
- Vedanta Aluminium, Oil & Gas and Power shares fall up to 5% on Day 2. What should investors do?Shares of newly demerged Vedanta entities saw a dip post-listing. Investors are now weighing long-term opportunities, with Vedanta Aluminiu...
- Lenskart block deal; Meesho's kirana pushLenskart has drawn fresh interest from major institutional investors. This and more in today's ETtech Top 5.
- Lenskart shares in focus as Goldman Sachs, Morgan Stanley, others purchase stake in Rs 1,960 crore block dealLenskart Solutions saw significant stake activity as marquee investors bought Rs 1,960 crore in a block deal, with Platinum Jasmine A 2018 ...
- Goldman Sachs, Morgan Stanley and others buy stake in Rs 1,960 crore Lenskart block dealADIA-backed Platinum Jasmine A 2018 Trust sold a 2.3% stake in Lenskart through a Rs 1,960 crore block deal. The transaction attracted stro...
- Parag Parikh Flexi Cap Fund raises stake in ITC, HDFC Bank and 14 other stocks in MayParag Parikh Flexi Cap Fund, India’s largest active flexi-cap scheme by AUM, raised exposure to ITC, HDFC Bank and 14 other stocks in May, ...
- Lenskart Solutions sees Rs 1,862-crore block deal; ADIA likely sellerEyewear retailer Lenskart Solutions experienced a significant block deal valued at Rs 1,862 crore. Abu Dhabi Investment Authority, through ...
- ADIA to sell Rs 1,944 crore Lenskart stake days after SoftBank exitAbu Dhabi Investment Authority (ADIA) is set to divest up to 2.3% of its stake in eyewear retailer Lenskart for approximately Rs 1,944 cror...
- PE investor BC Investments sells Rs 612 crore stake in Emcure Pharma; Kotak MF picks up stakePrivate equity firm BC Investments IV sold a Rs 612 crore stake in Emcure Pharmaceuticals to Kotak Mahindra Mutual Fund at Rs 1,700 per sha...
- Promoter sells Rs 1,024 crore worth of Ajanta Pharma shares in block deal to Kotak MF and ABSL MFA promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya B...
Load More
